Clinical Trial Update: The Effect of Betahistine on Body Weight in Obese Subjects [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating betahistine for reducing body weight in obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Betahistine (betahistine)

Snippet

Sponsor: OBEcure Ltd. | Conditions: Obesity | Phase 2 | Status: COMPLETED